Shares of Shilpa Medicare will be highlighted as its subsidiary, Shilpa Pharma Lifesciences, obtained a certificate of suitability from European regulators for Desmopressin. This API is used in diabetes treatment. The certification marks a milestone for the company. Shilpa Medicare’s stock has increased notably in 2024 despite recent declines.
Posts in category Economic Times
Stock to watch: M&M shares in focus after Thar Roxx sets record with 1.76 lakh bookings in just 60 minutes (04-10-2024)
Mahindra & Mahindra’s newly launched Thar ROXX garnered 1.76 lakh bookings within the first hour, marking record-breaking figures. Deliveries start on Dussehra day. Strong consumer interest underscores its market appeal. Additionally, Mahindra announced its entry into the electric small commercial segment with the ZEO four-wheeler.
ETMarkets Smart Talk: The Psychology of investing! Stay grounded in a bull market, says Nimesh Chandan (04-10-2024)
Swaying with the pendulum of market mood can compel the investor to buy during a bubble and sell during a crash. But it is important to understand that such behavior will not lead to superior returns.
Bajaj Housing Finance stock in focus as AUM crosses Rs 1 Lakh crore in first business update post-listing (04-10-2024)
Bajaj Housing Finance focuses on its debut business update, reporting AUM of Rs 1,02,550 crore, up 26% YoY. Loan assets rose to Rs 89,860 crore. The stock debuted with a 135% gain. Bajaj Finance also reported 92.09 million customers and a 14% increase in new loans, while its deposits grew by 21%.
Stock Watch: PNB shares in spotlight on Q2 business update (04-10-2024)
Shares of Punjab National Bank will be in focus today after the bank posted an 11% YoY growth in domestic business to Rs 24.30 lakh crore for Q2 FY24. Domestic deposits rose 11% to Rs 14.17 lakh crore, while domestic advances increased 12% to Rs 10.12 lakh crore.
Rajiv Jain is unimpressed by China stock mania sweeping globe (04-10-2024)
he manager of the top-performing $23 billion GQG Partners Emerging Markets Equity Fund has kept his holdings in Chinese stocks at about 12% of the fund — roughly half of the weighting of its benchmark
No structural downside, liquidity to cushion market dips: Mayuresh Joshi (04-10-2024)
Markets are fearful of Middle East conflict escalation, which might impact Q2 and Q3 earnings. However, liquidity remains robust, and rural recovery is expected in the second half of the year. Reliance’s core business might see softness, but retail and Jio should perform well. Auto stocks are holding on despite discounts indicating future stability and growth.